All sites C00-96,D32-33,D42-43,D45-47,D76 417 90.1 1.4 3.9 1.2 3.3
Mouth, pharynx C00-14 5 96.3 - 3.7 - -
  Lip C00 0 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 1 83.3 - 16.7 - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 77 81.3 2.6 9.9 2.6 3.6
  Oesophagus C15 2 91.7 - 8.3 - -
  Stomach C16 6 90.0 - 6.7 3.3 -
  Small intestine C17 1 85.7 - - - 14.3
  Colon C18 28 94.9 - 1.4 0.7 2.9
  Rectum, rectosigmoid C19-20 11 98.1 - - 1.9 -
  Anus C21 1 100.0 - - - -
  Liver C22 5 59.3 - 22.2 7.4 11.1
  Gallbladder, bile ducts C23-24 5 68.0 12.0 12.0 8.0 -
  Pancreas C25 17 55.8 8.1 25.6 3.5 7.0
  Other digestive organs C26 1 33.3 - 66.7 - -
Respiratory organs C30-39 24 74.6 3.3 13.9 0.8 7.4
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 - - - - - -
  Lung, trachea C33-34 23 76.7 3.4 12.9 0.9 6.0
  Mediastinum, pleura C38 1 - - 33.3 - 66.7
Bone C40-41 1 100.0 - - - -
Melanoma of the skin C43 17 100.0 - - - -
Skin, non-melanoma C44 28 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 94.1 - - - 5.9
Breast C50 126 98.6 0.2 0.2 0.5 0.6
Female genital organs C51-58 43 99.5 - - - 0.5
  Cervix uteri C53 4 100.0 - - - -
  Corpus uteri C54 20 100.0 - - - -
  Uterus, other C55,C58 - - - - - -
  Ovary C56 14 98.5 - - - 1.5
  Other female genital C51-52,C57 5 100.0 - - - -
Urinary organs C64-68 21 92.5 - 3.7 - 3.7
  Kidney C64 13 89.2 - 4.6 - 6.2
  Bladder and urinary tract2 C65-68 8 97.6 - 2.4 - -
Eye C69 0 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 14 82.9 - 10.0 - 7.1
Thyroid gland C73 4 100.0 - - - -
Other endocrine glands C74-75 0 100.0 - - - -
Illdefined or unknown C76,C80 12 58.3 1.7 20.0 10.0 10.0
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 39 76.5 7.1 0.5 3.1 12.8
  Hodgkin lymphoma C81 2 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 15 97.4 - - - 2.6
  Malignant immunoproliferative diseases C88 0 100.0 - - - -
  Myeloma and other plasma cell tumors C90 6 75.0 3.6 3.6 10.7 7.1
  Leukaemia C91-95 10 50.0 24.0 - 2.0 24.0
  Myelodysplastic syndromes D46 2 - 11.1 - 11.1 77.8
  Myeloproliferaitive neoplasms D45,D47 4 85.7 - - 4.8 9.5
Not included above
  Carcinoma in situ of the breast D05 10 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 8 100.0 - - - -
  Borderline tumour of the ovary D39 5 95.8 - 4.2 - -
  Basal cell carcinoma of the skin 78 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.